First Time Loading...

Shanghai Rongtai Health Technology Corp Ltd
SSE:603579

Watchlist Manager
Shanghai Rongtai Health Technology Corp Ltd Logo
Shanghai Rongtai Health Technology Corp Ltd
SSE:603579
Watchlist
Price: 19.03 CNY 1.49% Market Closed
Updated: Mar 28, 2024

Income Statement

Earnings Waterfall
Shanghai Rongtai Health Technology Corp Ltd

Revenue
1.7B CNY
Cost of Revenue
-1.2B CNY
Gross Profit
524.3m CNY
Operating Expenses
-356.8m CNY
Operating Income
167.5m CNY
Other Expenses
22.8m CNY
Net Income
190.3m CNY

Income Statement
Shanghai Rongtai Health Technology Corp Ltd

Rotate your device to view
Income Statement
Currency: CNY
Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023
Revenue
Revenue
1 192
N/A
1 285
+8%
1 370
+7%
1 515
+11%
1 709
+13%
1 918
+12%
2 155
+12%
2 332
+8%
2 398
+3%
2 296
-4%
2 204
-4%
2 157
-2%
2 167
+0%
2 314
+7%
2 129
-8%
2 096
-2%
2 090
0%
2 021
-3%
2 215
+10%
2 390
+8%
2 480
+4%
2 613
+5%
2 657
+2%
2 466
-7%
2 310
-6%
2 005
-13%
1 826
-9%
1 793
-2%
1 741
-3%
Gross Profit
Cost of Revenue
(751)
(797)
(845)
(927)
(1 049)
(1 188)
(1 360)
(1 504)
(1 580)
(1 516)
(1 492)
(1 482)
(1 498)
(1 596)
(1 456)
(1 415)
(1 395)
(1 443)
(1 586)
(1 746)
(1 855)
(1 913)
(1 964)
(1 840)
(1 711)
(1 476)
(1 344)
(1 276)
(1 216)
Gross Profit
441
N/A
488
+11%
525
+8%
588
+12%
660
+12%
730
+11%
796
+9%
828
+4%
818
-1%
780
-5%
712
-9%
675
-5%
669
-1%
718
+7%
673
-6%
681
+1%
695
+2%
577
-17%
629
+9%
644
+2%
625
-3%
700
+12%
693
-1%
626
-10%
599
-4%
528
-12%
482
-9%
517
+7%
524
+1%
Operating Income
Operating Expenses
(232)
(278)
(299)
(339)
(388)
(441)
(477)
(499)
(498)
(449)
(457)
(444)
(444)
(437)
(414)
(412)
(410)
(376)
(382)
(396)
(395)
(501)
(500)
(474)
(471)
(394)
(365)
(370)
(357)
Selling, General & Administrative
(232)
(210)
(297)
(337)
(385)
(333)
(346)
(342)
(321)
(354)
(359)
(340)
(331)
(311)
(300)
(312)
(310)
(281)
(290)
(295)
(298)
(381)
(400)
(385)
(386)
(301)
(300)
(302)
(287)
Research & Development
0
(61)
0
0
0
(99)
(132)
(159)
(185)
(104)
(95)
(106)
(114)
(118)
(127)
(112)
(106)
(96)
(104)
(114)
(116)
(114)
(118)
(107)
(101)
(85)
(81)
(80)
(78)
Depreciation & Amortization
0
(6)
0
0
0
(12)
0
0
0
(19)
0
0
0
(17)
0
0
0
(16)
0
0
0
(22)
0
0
0
(24)
0
0
0
Other Operating Expenses
0
(2)
(2)
(2)
(3)
3
1
2
8
28
(2)
2
1
8
13
12
7
17
12
14
20
16
18
18
16
16
15
12
8
Operating Income
209
N/A
210
+0%
226
+8%
250
+10%
272
+9%
289
+6%
319
+10%
329
+3%
320
-3%
330
+3%
255
-23%
231
-10%
225
-2%
280
+24%
258
-8%
269
+4%
286
+6%
201
-29%
247
+23%
249
+1%
230
-8%
199
-13%
192
-3%
151
-21%
128
-15%
135
+5%
117
-13%
147
+26%
168
+14%
Pre-Tax Income
Interest Income Expense
11
23
19
3
(11)
(32)
(60)
(42)
(39)
(41)
16
13
34
37
29
26
11
(4)
(7)
1
7
24
66
65
80
52
45
51
36
Non-Reccuring Items
0
0
0
0
0
(0)
0
0
(1)
(10)
(1)
25
43
9
11
(15)
(32)
2
2
1
1
41
1
2
2
0
0
0
(0)
Total Other Income
8
10
9
8
10
3
3
3
1
2
2
(0)
0
1
(1)
(1)
(2)
(1)
(2)
(2)
(3)
(3)
(4)
(11)
(10)
(7)
(7)
1
3
Pre-Tax Income
228
N/A
243
+7%
255
+5%
262
+3%
271
+4%
260
-4%
262
+1%
289
+11%
282
-3%
282
+0%
272
-4%
269
-1%
302
+12%
328
+9%
297
-9%
279
-6%
264
-6%
198
-25%
241
+21%
248
+3%
235
-5%
261
+11%
255
-2%
207
-19%
200
-3%
179
-10%
155
-13%
199
+28%
206
+4%
Net Income
Tax Provision
(30)
(34)
(38)
(38)
(40)
(33)
(31)
(34)
(29)
(32)
(30)
(29)
(35)
(40)
(36)
(34)
(32)
(17)
(18)
(19)
(20)
(33)
(37)
(32)
(30)
(15)
(11)
(15)
(15)
Income from Continuing Operations
198
209
217
224
232
227
231
256
253
250
242
240
267
288
262
245
231
181
222
228
215
228
218
175
169
165
144
183
191
Income to Minority Interest
(2)
(2)
(5)
(7)
(10)
(10)
(11)
(9)
(8)
(1)
7
5
7
7
6
13
15
12
10
6
7
8
8
7
4
(0)
(0)
(1)
(1)
Net Income (Common)
196
N/A
207
+5%
212
+3%
218
+3%
222
+2%
216
-3%
220
+2%
246
+12%
245
-1%
249
+2%
249
0%
245
-2%
274
+12%
296
+8%
267
-10%
258
-4%
246
-4%
193
-22%
232
+20%
234
+1%
222
-5%
236
+6%
226
-4%
182
-19%
173
-5%
164
-5%
143
-13%
183
+27%
190
+4%

See Also

Discover More